MaxWell Biosystems Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

MaxWell Biosystems General Information

Description

Developer of an electrophysiology cell imaging platform designed to accelerate drug discovery. The company's platform works on electrophysiology technology and consists of an integrated sensor chip, acquisition hardware, and software to deliver accurate results, enabling researchers to shorten the process of characterizing the function of every cell from several months to a few weeks.

Contact Information

Website
www.mxwbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Albisriederstrasse 253
  • 8047 Zurich
  • Switzerland
+41 044
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
TMT
Corporate Office
  • Albisriederstrasse 253
  • 8047 Zurich
  • Switzerland
+41 044

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MaxWell Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Mar-2026 Completed Generating Revenue
4. Early Stage VC (Series A) 16-Dec-2020 Completed Generating Revenue
3. Seed Round 10-May-2017 Completed Generating Revenue
2. Grant 02-Nov-2016 $20.3K Completed Generating Revenue
1. University Spin-Out 01-Sep-2016 Completed Startup
To view MaxWell Biosystems’s complete valuation and funding history, request access »

MaxWell Biosystems Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Series A
To view MaxWell Biosystems’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

MaxWell Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an electrophysiology cell imaging platform designed to accelerate drug discovery. The company's platform wo
Discovery Tools (Healthcare)
Zurich, Switzerland
52 As of 2026

Atlanta, GA
 

Schwyz, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MaxWell Biosystems Competitors (2)

One of MaxWell Biosystems’s 2 competitors is Axion Biosystems, a Private Equity-Backed company based in Atlanta, GA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axion Biosystems Private Equity-Backed Atlanta, GA
3Brain Venture Capital-Backed Schwyz, Switzerland
You’re viewing 2 of 2 competitors. Get the full list »

MaxWell Biosystems Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

MaxWell Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025181295-A1 Multi-receptacle micro-electrode array device Pending 01-Mar-2024

MaxWell Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MaxWell Biosystems Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sensirion Holding Corporation Minority
ETH Zurich University
To view MaxWell Biosystems’s complete investors history, request access »

Ready to get started?

Request a free trial

MaxWell Biosystems FAQs

  • When was MaxWell Biosystems founded?

    MaxWell Biosystems was founded in 2016.

  • Where is MaxWell Biosystems headquartered?

    MaxWell Biosystems is headquartered in Zurich, Switzerland.

  • What is the size of MaxWell Biosystems?

    MaxWell Biosystems has 52 total employees.

  • What industry is MaxWell Biosystems in?

    MaxWell Biosystems’s primary industry is Discovery Tools (Healthcare).

  • Is MaxWell Biosystems a private or public company?

    MaxWell Biosystems is a Private company.

  • What is MaxWell Biosystems’s current revenue?

    The current revenue for MaxWell Biosystems is .

  • How much funding has MaxWell Biosystems raised over time?

    MaxWell Biosystems has raised $4.71M.

  • Who are MaxWell Biosystems’s investors?

    Sensirion Holding and ETH Zurich have invested in MaxWell Biosystems.

  • Who are MaxWell Biosystems’s competitors?

    Axion Biosystems and 3Brain are competitors of MaxWell Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process